• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Loratadine specified impurity F Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756554

MBS5756554 is an inhibitor targeting Loratadine specified impurity F. Loratadine specified impurity F is a fluorinated analog of Loratadine. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Loratadine specified impurity F, Inhibitor
Full Product Name
Loratadine specified impurity F
Product Synonym Names
11-Fluoro dihydroloratadine
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
402.89
Solubility
DMSO: Soluble
(<1mg/ refers to the product slightly soluble or insoluble)
Formula
C22H24ClFN2O2
SMILES
O=C(N1CCC(C2(F)C3=CC=C(Cl)C=C3CCC4=CC=CN=C42)CC1)OCC
CAS Number
125743-80-8

Product References and Citations for Loratadine specified impurity F, inhibitor

Patel JZ, Ahenkorah S, Vaara M, Staszewski M, Adams Y, Laitinen T, Navia-Paldanius D, Parkkari T, Savinainen JR, WalczyA, ski K, Laitinen JT, Nevalainen TJ. Loratadine analogues as MAGL inhibitors. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1436-42. doi: 10.1016/j. Bmcl.2015.02.037. Epub 2015 Feb 24. PubMed PMID: 25752982.
Baumann-Birkbeck L, Grant GD, Anoopkumar-Dukie S, Kavanagh JJ. Drowsiness and motor responses to consecutive daily doses of promethazine and loratadine. Clin Neurophysiol. 2014 Dec;125(12):2390-6. doi: 10.1016/j.clinph.2014.03.026. Epub 2014 Apr 12. PubMed PMID: 24791618.
Li W, Doherty J, Moench P, Flarakos J, Tse FL. LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Mar 1;983-984:117-24. doi: 10.1016/j.jchromb.2014.12.033. Epub 2015 Jan 13. PubMed PMID: 25645810.
Li H, Tan Y, Yang L, Gao L, Wang T, Yang X, Quan D. Dissolution evaluation in vitro and bioavailability in vivo of self-microemulsifying drug delivery systems for pH-sensitive drug loratadine. J Microencapsul. 2015;32(2):175-80. doi: 10.3109/02652048.2014.985340. Epub 2014 Nov 21. PubMed PMID: 25413271.

Other Notes

Small volumes of Loratadine specified impurity F, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000